Woman Hospitalized After Using Unlicensed Weight-Loss Injections, Highlighting Black Market Dangers
Kay Roscoe, a 38-year-old woman from Birkenhead, UK, was hospitalized with severe hypoglycemia after injecting an unlicensed substance sold as retatrutide, an experimental weight-loss drug, for approximately two months. Roscoe, who purchased the injection from a friend and believed it was genuine due to a QR code leading to a seemingly pharmaceutical website, experienced a dangerous drop in blood sugar levels. Doctors warned she could have died if found later. The incident has prompted Roscoe to caution others against using unregulated slimming injections, reporting continued health problems including liver damage and high cholesterol, which she did not have previously. This case underscores the significant risks associated with black market weight-loss products.